Key Takeaways
- • Prenetics' IM8 health and wellness brand secured approximately $1 billion in growth financing from General Catalyst, representing a significant institutional validation of the direct-to-consumer supplement platform co-founded by David Beckham.
- • IM8 was tracking toward $120 million in annual recurring revenue (ARR) by December 2025, demonstrating rapid commercial traction and positioning it as the fastest-growing supplement brand in its category.
- • The funding round reflects broader investor appetite for digital-native health and wellness platforms, with General Catalyst's participation indicating confidence in IM8's market expansion potential across hair loss, anti-aging, and peptide categories.
- • Prenetics has diversified its capital strategy beyond traditional venture funding, securing equity investments from alternative sources including MLS team Inter Miami CF, alongside the primary growth round.
Summary
Prenetics, the parent company of IM8, has secured approximately $1 billion in growth financing led by General Catalyst, according to Bloomberg reporting. The funding represents a substantial institutional commitment to the direct-to-consumer supplement brand, which was co-founded by David Beckham and has established itself as a high-growth player in the digital wellness market.
The financing validates IM8's commercial momentum. As of third quarter 2025, the brand was on track to reach $120 million in annual recurring revenue by December 2025, establishing it as the fastest-growing supplement brand in its segment. This revenue trajectory underscores the strength of its customer acquisition and retention model within the competitive health and wellness e-commerce landscape.
General Catalyst's lead investment signals institutional confidence in IM8's expansion strategy, particularly into adjacent categories including hair loss treatments, anti-aging products, and peptide-based supplements. These categories represent high-margin opportunities within the broader $150+ billion global supplement market, where digital-native brands have captured significant share from traditional retailers.
Prenetics has also diversified its capital structure beyond traditional venture and growth equity sources. The company secured an additional equity investment from MLS team Inter Miami CF, creating a potentially valuable branding and distribution partnership within sports and lifestyle segments. This multi-source funding approach reflects both the company's growing attractiveness to diverse investor classes and a strategic effort to build integrated marketing and community channels beyond conventional digital channels.
The financing validates IM8's commercial momentum. As of third quarter 2025, the brand was on track to reach $120 million in annual recurring revenue by December 2025, establishing it as the fastest-growing supplement brand in its segment. This revenue trajectory underscores the strength of its customer acquisition and retention model within the competitive health and wellness e-commerce landscape.
General Catalyst's lead investment signals institutional confidence in IM8's expansion strategy, particularly into adjacent categories including hair loss treatments, anti-aging products, and peptide-based supplements. These categories represent high-margin opportunities within the broader $150+ billion global supplement market, where digital-native brands have captured significant share from traditional retailers.
Prenetics has also diversified its capital structure beyond traditional venture and growth equity sources. The company secured an additional equity investment from MLS team Inter Miami CF, creating a potentially valuable branding and distribution partnership within sports and lifestyle segments. This multi-source funding approach reflects both the company's growing attractiveness to diverse investor classes and a strategic effort to build integrated marketing and community channels beyond conventional digital channels.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.